Stilla's Naica, a six-color digital PCR system. Image courtesy of Stilla.

The Naica system supports cell and gene therapy research, cancer and liquid biopsy studies, the detection of infectious diseases in wastewater and food, and environmental testing, Stilla said.

At the American Society of Human Genetics meeting, Stilla and researchers from Saga Diagnostics in Lund, Sweden, presented a 24-plex digital PCR assay generated on the Naica system, according to the firm.

"From quantifying circulating tumor cells and cell-free DNA in liquid biopsies for oncology, to detecting low-level genetic variants in infectious diseases, multiplex digital PCR is allowing researchers to parse complex genomics data to gain real-world, clinical insights at both the patient and the population level," Rémi Dangla, PhD, co-founder and chief technology officer at Stilla, said in a statement.

Stilla launches 6-color digital PCR system
Stilla Technologies has launched its six-color Crystal Digital PCR access program, which provides the industry with early access to its digital polymerase...